Time Isn’t on Valeant’s Side in Allergan Bid
Time Isn’t on Valeant’s Side in Allergan Bid Barron's
View ArticleResponding to critics, Valeant CEO says company can grow organically
Responding to critics, Valeant CEO says company can grow organically Marketwatch
View ArticleAllergan, Actavis Top Big Cap Pharmas Amid M&A Flurry
Allergan, Actavis Top Big Cap Pharmas Amid M&A Flurry Investors.com
View ArticleThe Race To The Market: Anacor and Valeant
The Race To The Market: Anacor and Valeant Motley Fool
View ArticleDrug-maker Valeant begins exchange offer for Allergan
Drug-maker Valeant begins exchange offer for Allergan Yahoo/Reuters
View ArticleThe Case For and Against Valeant Pharmaceuticals
The Case For and Against Valeant Pharmaceuticals Motley Fool
View ArticleWill Allergan scramble for Shire to beat off Valeant's hostile advance?
Will Allergan scramble for Shire to beat off Valeant's hostile advance? Fierce Pharma
View ArticleAllergan Should Buy Perrigo For A Tax Inversion; Before Someone Else Does
Allergan Should Buy Perrigo For A Tax Inversion; Before Someone Else Does Seeking Alpha
View ArticleAllergan advises shareholders against Valeant tender offer
Allergan advises shareholders against Valeant tender offer Yahoo/Reuters
View ArticleAllergan, Valeant trade rapid-fire salvos in ongoing takeover battle
Allergan, Valeant trade rapid-fire salvos in ongoing takeover battle Marketwatch
View ArticleBiotech Stocks to Watch Today: Agenus, Allergan and Auxilium Pharmaceuticals
Biotech Stocks to Watch Today: Agenus, Allergan and Auxilium Pharmaceuticals Motley Fool
View ArticleU.S. Senators Seek Review for Hostile Bid on Allergan
U.S. Senators Seek Review for Hostile Bid on Allergan Bloomberg
View ArticleAllergan says U.S. FDA sent 2nd letter on acute migraine treatment
Allergan says U.S. FDA sent 2nd letter on acute migraine treatment Yahoo/Reuters
View ArticleDEALTALK-Allergan readies defense as it fights Valeant for votes
DEALTALK-Allergan readies defense as it fights Valeant for votes Reuters
View ArticleAllergan readies defense as it fights Valeant for votes
Allergan readies defense as it fights Valeant for votes Yahoo/Reuters
View ArticleInvestor Ackman hires Credit Suisse for Allergan bid -source
Investor Ackman hires Credit Suisse for Allergan bid -source Yahoo/Reuters
View ArticleAckman proposes new slate of Allergan directors amid takeover war
Ackman proposes new slate of Allergan directors amid takeover war Marketwatch
View ArticleAllergan Said to Plan Cost Cuts Amid Valeant Defense
Allergan Said to Plan Cost Cuts Amid Valeant Defense Bloomberg
View ArticleHow Will Allergan (AGN) Stock React To New Restructuring Plan?
How Will Allergan (AGN) Stock React To New Restructuring Plan? TheStreet.com
View Article